Stocks With Hourly RSI Above 70 on 21 November 2025
| Number | Ticker | Country | Market Cap | AVG Volume | Price | Hourly RSI |
|---|---|---|---|---|---|---|
| 1 | United States | $449.6B | 8.6M | $203.91 | 75.23 | |
| 2 | Israel | $307.5M | 9.2K | $24.20 | 70.11 | |
| 3 | United States | $859.6M | 186.7K | $25.60 | 75.69 | |
| 4 | United States | $817.1B | 17.3M | $107.53 | 72.84 | |
| 5 | United States | $69.7B | 1.6M | $218.47 | 75.02 | |
| 6 | United States | $53.3M | 3.2M | $3.95 | 70.92 | |
| 7 | CCHHCCH Holdings Ltd Ordinary Shares | Malaysia | $113.0M | 609.6K | $7.92 | 86.32 |
| 8 | France | $299.0M | 88.9K | $4.79 | 70.40 | |
| 9 | United States | $244.3M | 93.8K | $4.88 | 74.52 | |
| 10 | United States | $2.6B | 1.9M | $16.38 | 72.17 | |
| 11 | United States | $844.2M | 357.9K | $20.94 | 87.58 | |
| 12 | United States | $773.2M | 18.9M | $1.44 | 70.48 | |
| 13 | United States | $102.9M | 32.4K | $10.68 | 74.83 | |
| 14 | United Kingdom | $63.8M | 6.4K | $2.23 | 75.97 | |
| 15 | United States | $93.9M | 431.5K | $3.12 | 72.11 | |
| 16 | United States | $155.4M | 587.9K | $0.98 | 71.17 | |
| 17 | United States | $11.0B | 7.2M | $100.88 | 94.57 | |
| 18 | United States | $2.8B | 2.2M | $219.67 | 87.54 | |
| 19 | NUVBNuvation Bio Inc. | United States | $1.7B | 12.0M | $6.97 | 71.04 |
| 20 | United Arab Emirates | $468.5M | 8.5M | $0.81 | 77.23 | |
| 21 | United States | $1.1B | 3.9M | $11.77 | 88.49 | |
| 22 | United States | $17.6B | 2.4M | $67.58 | 71.35 | |
| 23 | United States | $80.8B | 2.5M | $216.67 | 70.28 | |
| 24 | United States | $1.3B | 564.2K | $36.22 | 77.16 | |
| 25 | United States | $278.8M | 104.9K | $16.68 | 74.07 | |
| 26 | United States | $2.1B | 2.2M | $25.96 | 76.77 | |
| 27 | MAGHMagnitude International Ltd Ordinary Shares | Singapore | $51.8M | 479.4K | $4.78 | 81.35 |
Share on Social Networks:
Disclaimer
The FinQuota filters have identified what they believe to be the "Best Stocks With Hourly RSI Above 70 on 21 November 2025" to buy now. However, please note that this information should not be considered as financial advice, as investing involves risks. We strongly recommend consulting with a qualified financial advisor before making any decisions regarding buying or selling stocks.